Talphera Q4 and Full Year 2025 Financial Update
Talphera is a specialty pharmaceutical company developing therapies for medically supervised settings. They are currently advancing their lead product candidate,...
ADVERTISEMENT
Earnings
Heidmar Maritime Holdings Corp. (HMR) Q4 Earnings: Misses on EPS, Revenue Recap
Substantial miss. Heidmar Maritime Holdings Corp. (NASDAQ:HMR) reported Q4 2025 GAAP earnings of -$0.07 per share, falling well short of…
Context Therapeutics 2025 Financial Review
Context Therapeutics is a clinical-stage biopharmaceutical company developing T cell engaging bispecific antibodies for solid tumors. The company reported a...
Lithium Argentina 2025 Financial Review
Lithium Argentina produces lithium carbonate primarily for the electric vehicle and battery markets. The company operates and holds a 44.8%...
Sanara MedTech Inc. (SMTI) Q4 Earnings: Misses on EPS, Revenue Recap
Disappointing quarter. Sanara MedTech Inc. (SMTI) reported Q4 2025 GAAP earnings of -$0.13 per share, falling short of the $0.11…
LightInTheBox Holding Co., Ltd. (LITB) Q4 2025 Earnings Recap
Impressive earnings acceleration. LightInTheBox Holding Co., Ltd. (NYSE:LITB) reported Q4 2025 adjusted earnings of $0.18 per share on revenue of…
AGI Q4 FY25 Earnings Results
AGI is a profitable fintech providing financial services to underserved Brazilians. It operates a hybrid business model combining digital platforms...
Formula Systems Q3 2025 Financial Review
Formula Systems is a global information technology group that provides software consulting services, computer-based business solutions, and proprietary software products....
Gemini Q4 and FY25 Financial Review
Gemini recently released its fourth quarter and full year 2025 financial results. The platform focuses on strengthening its core exchange...
FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue
FedEx Q3 EPS of $5.25 crushed the $4.13 estimate by 27%, with revenue of $24B topping consensus on 8.3% year-over-year…